Anti-signal recognition particle antibody-positive immune-mediated necrotizing myopathy with inclusion body myositis-like features in a patient with human immunodeficiency virus and syphilis infection.

The clinical, serological and myopathological features of a cohort of Chinese patients with inclusion body myositis: a single center analysis.

Prevalence and Risk of Falls and Fractures in the Idiopathic Inflammatory Myopathies: A Cross-Sectional Study of 470 Patients.

The Myositis Overlap Conundrum: Differentiating Polymyositis from Inclusion Body Myositis.

Semi-quantitative analyses of muscle magnetic resonance imaging for pattern recognition in early idiopathic inflammatory myopathies.

Fatal Cardiomyopathy Secondary to Seronegative Immune-Mediated Necrotizing Myopathy: A Case Report.

Modifying muscle metabolic dysregulation in inclusion body myositis with pioglitazone: a single-arm trial.

Evaluation of Dysphagia in Myositis and Muscular Dystrophy Using Real-Time MRI and Quantitative Muscle Ultrasound.

Lead Toxicity Masquerading as Autoimmune Haemolytic Anaemia: A Diagnostic Pitfall in Unexplained Anaemia.

Multilevel impairment of mitochondrial respiration with sex-specific signatures in inclusion body myositis.

Mitochondrial abnormalities in idiopathic inflammatory myopathies.

Improved Detection of Myositis-Specific Autoantibodies Using Luciferase Immunoprecipitation Systems Assay: Comparison with Line Blot and Conventional Immunoprecipitation.

Spatial protein expression patterns across pathologically-associated fibers revealed molecular specialization in inclusion body myositis.

Association between Oropharyngeal Dysphagia and Subgroups of Patients with Idiopathic Inflammatory Myopathy: A Cross-Sectional Study.

Potential pitfalls in the differential diagnosis of myositis versus hereditary myopathies.

cN1A Antibody-Positive Inclusion Body Myositis Following Seminoma Manifesting With Slowly Progressive Paraparesis: A Case Report.

Kinematic features of dysphagia in inclusion body myositis.

Proteomic profiles in inclusion body myositis and polymyositis with mitochondrial pathology.

Quadriceps and ankle weakness in inclusion body myositis: impact on descending balance control and rehabilitation strategies - a systematic review.

A 73-Year-Old Man With Several Years of Difficulty Climbing Stairs and Frequent Tripping.

The Role of Imaging Techniques in the Evaluation of Extraglandular Manifestations in Patients with Sjögren's Syndrome.

The MicroIBioM study: the gut microbiome in inclusion body myositis.

Muscle Imaging in Inclusion Body Myositis: Refinement of MRI Criteria and Insights Into Upper Body Involvement.

Expanding the Differential Diagnosis of Ultrasonographic Flexor Digitorum Profundus-Flexor Carpi Ulnaris Dissociation of Echogenicity: Muscular Dystrophies.

Immunotherapies in autoimmune inflammatory myopathies: Rationale and therapeutic updates.

The immune cell landscape analysed by imaging mass cytometry in the muscle of patients with inclusion body myositis associated or not with Sjögren's disease.

Immune-Driven Expression in Inclusion Body Myositis With T-Cell Large Granular Lymphocytic Leukemia.

Spatially Resolved Profiling of Compartmentalized Muscle and Brain Inflammation.

Tocilizumab in the Treatment of Sporadic Inclusion Body Myositis.

[A case of gastric emphysema with intra-abdominal free air that resolved with conservative treatment].

Muscle mitochondrial changes in antisynthetase syndrome and other idiopathic inflammatory myopathies.

Antisense oligonucleotides targeting valosin-containing protein ameliorate muscle pathology and molecular defects in cell and mouse models of multisystem proteinopathy.

Comorbidities in idiopathic inflammatory myopathies: population-based evidence on risk subgroups and implications for delivery of care.

Dermatomyositis and microscopic polyangiitis overlap: a case-based review.

Obturator hernia associated with inclusion body myositis: a case report.

Case Report: Progressive interstitial lung disease secondary to Sjögren's disease in a patient with inclusion body myositis complicated by dysphagia-a multidisciplinary approach and therapeutic challenges.

Altered Transcriptome Signature in Primary Human Myotubes Exposed to Inclusion Body Myositis Serum: A Pilot Case Comparison of Anti-cN1A Positive and Negative Sera.

Assessment of IBM-FRS total score and specific functional domains in a large cohort of inclusion body myositis patients.

Murine toxicology assessment of avgn7.2, a novel gene therapeutic for inclusion body myositis and other muscle wasting diseases.

Bimagrumab: Novel Medical Therapy for Inclusion Body Myositis, Sarcopenia, and Medication-Induced Lean Body Mass Loss.

Unmasking Idiopathic Inflammatory Myopathy: A Case of Proximal Weakness in a Young Male With Co-Occurring Vitamin D Deficiency.

Revisiting the link between oropharyngeal dysphagia and cancer in autoimmune myositis: a descriptive study.

[A case of inclusion body myositis with childhood onset].

Nailfold videocapillaroscopy abnormalities in autoimmune inflammatory myopathy subsets.

The PTPN22 R620W polymorphism is associated with inclusion body myositis: data from the UKMyoNet study.

The Mythology of Polymyositis.

Emerging Treatment Options for Inclusion Body Myositis.

Updates on Diagnostic Criteria of Inclusion Body Myositis.

Epidemiology of Dermatomyositis and Other Idiopathic Inflammatory Myopathies in Northern Spain.

Concerns Regarding "Small Fiber Morphology and Function in Inclusion Body Myositis-A Multimodal Assessment Including Confocal Corneal Microscopy".

A case of Inclusion Body Myositis with Isolated Dysphagia: An Earlier-stage Diagnosis Using a Surgical Specimen from Cricopharyngeal Myotomy.

Recent advances in immunological mechanisms and murine disease models of idiopathic inflammatory myopathies.

Enhanced proteasome activity in perifascicular myofibres is a hallmark of dermatomyositis and its inhibition is efficient in preclinical models.

SNUPN-Related Muscular Dystrophy: Novel Phenotypic, Pathological and Functional Protein Insights.

Idiopathic inflammatory myopathy associated with Sjögren's disease: features of a distinct clinical entity.

N-formyl methionine peptide-driven neutrophil activation in idiopathic inflammatory myopathies.

Prevalence of vasculitis, systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis, idiopathic inflammatory myopathies and spondyloarthritis in Australia: a systematic review and meta-analysis.

Myopathology and Immune Profile of Granulomatous Myositis in Sarcoid Myopathy.

Long-term oral glucocorticoid use is associated with complications, healthcare resource utilization, and costs among patients with dermatomyositis or polymyositis.

A Scoping Review of Respiratory Dysfunction in Inclusion Body Myositis.

Dual probe ligation in situ hybridization with rolling-circle amplification for high-plex spatial transcriptomics.

Mutual reinforcement of lymphotoxin-driven myositis and impaired autophagy in murine muscle.

[Not just frailty-Sjögren's syndrome and polymyositis with mitochondrial pathology].

Prevalence and functional characterization of anti-interferon autoantibodies in inflammatory myopathies.

Genetics of myositis - distinct backgrounds of subtypes.

Small Fiber Morphology and Function in Inclusion Body Myositis-A Multimodal Assessment Including Confocal Corneal Microscopy.

Lymphocyte Activation Gene 3 in Inclusion Body Myositis: A Novel Therapeutic Biomarker?

Before Coming to the Conclusion That Inclusion Body Myositis Is a Risk Factor for a Heart Attack, All Influencing Factors Must Be Taken Into Account.

TDP-43 pathology induces CD8+ T cell activation through cryptic epitope recognition.

A Case of Anti-TIF1γ Antibody-Positive Dermatomyositis Associated With Malignancy.

The clinical features, muscle pathology, and role of autophagy in anti-Ku-positive patients.

Case Report of an Atypical Presentation of Inclusion Body Myositis Masquerading as Polymyalgia Rheumatica.

Coexistence of Mycosis Fungoides and Photosensitive or Autoimmune Diseases. The Therapeutic Challenge: A retrospective Case Series from a Tertiary Referral Center.

Mitochondrial pathology in inflammatory myopathies: a marker of worse clinical outcome.

Expression and Site-Specific Biotinylation of Human Cytosolic 5'-Nucleotidase 1A in Escherichia coli.

Infections preceding diagnosis associated with myositis phenotypes in a national patient registry.

Treatment of idiopathic inflammatory myopathies.

Cardiac involvement in established idiopathic inflammatory myopathy assessed by cardiac magnetic resonance mapping.

Activated Dendritic Cell Subsets Characterize Muscle of Inclusion Body Myositis Patients and Correlate with KLRG1+ and TBX21+ CD8+ T cells.

Local immunoglobulin expression in myositis is associated with interferon gamma signaling and correlates with disease activity.

LAG3 Is Expressed on Muscle-Infiltrating Cytotoxic T Cells, but Scarce on Circulating T Cells, in Patients With Inclusion Body Myositis.

Ageing Signatures and Disturbed Muscle Regeneration in Muscle Proteome of Inclusion Body Myositis.

Inclusion body myositis - what are new lines of pathogenesis and therapy?

Mitochondria-centred metabolomic map of inclusion body myositis: sex-specific alterations in central carbon metabolism.

Characterizing local antibody responses in the muscle of inclusion body myositis patients.

Alpha-Synuclein as a Potential Biomarker for Inclusion Body Myositis in Blood and Muscle.

Rheumatic manifestations of HIV/AIDS.

Inclusion Body Myositis: A Case Report.

The Role of Repeat Skeletal Muscle Biopsy: Indications, Yield and Outcomes.

Concurrent Inclusion Body Myositis and Late Onset Pompe Disease: A Case Report.

Increased Risk of Myocardial Infarction in Inclusion Body Myositis: A Non-Concurrent Cohort Study.

Interferon-γ causes myogenic cell dysfunction and senescence in immune myopathies.

Autophagy in myositis, a dysregulated pathway, and a target for therapy.

Chronic sarcoid myopathy mimicking facioscapulohumeral muscular dystrophy: a case report.

Idiopathic Inflammatory Myopathies: Recent Evidence Linking Pathogenesis and Clinical Features.

Mitochondrial damage is associated with an early immune response in inclusion body myositis.

Strapped for Strength: A Comparison Study of Dynamometry Techniques to Evaluate Knee Extensor Strength in Inclusion Body Myositis.

Converging Inflammations: Simultaneous Myositis and Polyneuropathy as a Diagnostic Challenge.

The caregiver burden of idiopathic inflammatory myopathies.

Cardiac Involvement in Idiopathic Inflammatory Myopathies.

A systematic review and meta-analysis of the response to placebo in clinical trials of inclusion body myositis.

Cardiovascular events in patients with myositis: results from a French retrospective cohort.

2024 VCP International Conference: Exploring multi-disciplinary approaches from basic science of valosin containing protein, an AAA+ ATPase protein, to the therapeutic advancement for VCP-associated multisystem proteinopathy.

Myopathic aggregation-prone variants in the TDP-43 prion-like domain: genetics paving the way.

Distinct Cytokine and Cytokine Receptor Expression Patterns Characterize Different Forms of Myositis.

Quantitative muscle magnetic resonance imaging as a biomarker for inclusion body myositis in clinical trials: exploring the in vivo effects of arimoclomol.

Challenges in international investigator-led rare disease clinical trials and the case for optimism in inclusion body myositis.

Optimism in inclusion body myositis: a double-blind randomised controlled phase III trial investigating the effect of sirolimus on disease progression in patients with IBM as measured by the IBM Functional Rating Scale.

Ultrasensitive interferons quantification reveals different cytokine profile secretion in inflammatory myopathies and can serve as biomarkers of activity in dermatomyositis.

Corrigendum: Applicability of a serodiagnostic line blot for idiopathic inflammatory myopathy: the muscle biopsy is not all.

Human induced pluripotent stem cell-derived myotubes to model inclusion body myositis.

Imaging evaluation of the upper limbs in inclusion body myositis: an unmet need.

Current biomarkers in inclusion body myositis.

Association of HLA-DR, HLA-DQ, and HLA-B alleles with inclusion body myositis risk: A systematic review, a meta-analysis, a meta-regression and a trial sequential analysis.

Determining patient and carer priorities in inclusion body myositis: a patient-led research study.

Emerging mechanisms and therapeutics in inflammatory muscle diseases.

The utility of muscle magnetic resonance imaging in idiopathic inflammatory myopathies: a scoping review.

Retrospective analysis of US veterans with inclusion body myositis: initial findings from the Veterans Affairs Corporate Data Warehouse.

Efficacy and safety of pharmacological treatments in inclusion body myositis: a systematic review.

Applicability of a serodiagnostic line blot for idiopathic inflammatory myopathy: the muscle biopsy is not all.

Artificial intelligence models using F-wave responses predict amyotrophic lateral sclerosis.

Safe and Orally Bioavailable Inhibitor of Serine Palmitoyltransferase Improves Age-Related Sarcopenia.

Multi-omics analysis in inclusion body myositis identifies mir-16 responsible for HLA overexpression.

Refining the clinical and therapeutic spectrum of granulomatous myositis from a large cohort of patients.

[Neurology: what's new in 2024].

The relationship between patient-reported and clinician-assessed outcome measures in Inclusion body myositis - insights from a retrospective cohort study.

Differentiating Inclusion Body Myositis From Amyotrophic Lateral Sclerosis Based on the Features of Dysphagia: Insights From a Patient With Rapidly Progressive Dysphagia.

Loss of TDP-43 Splicing Repression Occurs in Myonuclei of Inclusion Body Myositis Patients.

NLRP3 Inflammasome Activation and Altered Mitophagy Are Key Pathways in Inclusion Body Myositis.

Inclusion Body Myositis: A case report on navigating diagnostic challenges.

Clinical Significance of Abnormal Serum LGALS3BP Expression in Patients with Idiopathic Inflammatory Myopathies.

Seeding-competent TDP-43 persists in human patient and mouse muscle.

Autoantibodies against a subunit of mitochondrial respiratory chain complex I in inclusion body myositis.

Occupational and Hobby Exposures Associated With Myositis Phenotypes in a National Myositis Patient Registry.

Inclusion body myositis and immunosenescence: current evidence and future perspectives.

Whole-body-electro-myostimulation for the care of inclusion body myositis-A case report.

Serum creatine kinase elevation following tyrosine kinase inhibitor treatment in cancer patients: Symptoms, mechanism, and clinical management.

Inclusion Body Myositis: A Late Diagnosis Case Report.

Inclusion body myositis: an update.

Intramyocardial fatty infiltration lesion in sporadic inclusion body myositis: a case report.

Late-onset primary muscle diseases mimicking sarcopenia.

Myositis-specific and myositis-associated autoantibodies: their clinical characteristics and potential pathogenic roles.

Features of Swallowing Function in Sporadic Inclusion Body Myositis: Preliminary Evidence Using Well-Tested Assessment Frameworks.

Volumetric muscle composition analysis in sporadic inclusion body myositis using fat-referenced magnetic resonance imaging: Disease pattern, repeatability, and natural progression.

Recent Updates on the Pathogenesis of Inflammatory Myopathies.

Inclusion body myositis: Correcting impaired mitochondrial and lysosomal autophagy as a potential therapeutic strategy.

Contribution of major histocompatibility complex class II immunostaining in distinguishing idiopathic inflammatory myopathy subgroups: A histopathological cohort study.

Pathogenic mechanisms of disease in idiopathic inflammatory myopathies: autoantibodies as clues.

TLR7/8 Activation in Immune Cells and Muscle by RNA-Containing Immune Complexes: Role in Inflammation and the Pathogenesis of Myositis.

What is in the Myopathy Literature?

Construct validity of PROMIS pain interference, fatigue, and physical function as patient-reported outcomes in adults with idiopathic inflammatory myopathies: An international study from the OMERACT myositis working group.

Impact of sex, age at onset, and anti-cN1A antibodies on sporadic inclusion body myositis.

Key target genes related to anti-breast cancer activity of ATRA: A network pharmacology, molecular docking and experimental investigation.

Watch for inclusion body myositis.

Sporadic inclusion body myositis-derived myotube culture revealed muscle cell-autonomous expression profiles.

Patient experiences of muscle biopsy in idiopathic inflammatory myopathies: a cross-sectional survey.

Anti-HMGCR myopathy: Diversity of clinical presentations in a national cohort in New Zealand.

Distinct Transcript-Level Expression Profiles and Unique Alternative Splicing in Inflammatory Myopathies.

Granulomatous myositis: characteristics and outcome from a monocentric retrospective cohort study.

Quantitative muscle MRI in sporadic inclusion body myositis (sIBM): A prospective cohort study.

Differentiating idiopathic inflammatory myopathies by automated morphometric analysis of MHC-1, MHC-2 and ICAM-1 in muscle tissue.

Anti-Ku + myositis: an acquired inflammatory protein-aggregate myopathy.

Measurement properties of the Inclusion Body Myositis Functional Rating Scale.

Association between ZASP/LDB3 Pro26Ser and Inclusion Body Myopathy.

Anti-HMGCR (Hydroxy-3-Methylglutaryl-CoA Reductase) Myopathy: A Rare Cause of Proximal Muscle Weakness.

Immunohistochemical expression in idiopathic inflammatory myopathies at a single center in Vietnam.

A case of acute hypercapnic respiratory failure secondary to late onset nemaline rod myopathy: A multi-disciplinary approach.

Treatment resistance in inclusion body myositis: the role of mast cells.

Anesthesia Spearheading Perioperative Safety Efforts in a Patient with Inclusion Body Myositis: A Case Report.

Cell type mapping of inflammatory muscle diseases highlights selective myofiber vulnerability in inclusion body myositis.

The prevalence, epidemiological characteristics and mortality trends of inflammatory myopathies patients in Oman: the Prevision study.

Mitochondrial defects in sporadic inclusion body myositis-causes and consequences.

Autoantibody evaluation in idiopathic inflammatory myopathies.

[Sporadic Inclusion Body Myositis].

Systemic sclerosis associated myopathy: how to treat.

Whole-body muscle magnetic resonance imaging in inflammatory myopathy with mitochondrial pathology.

Compound muscle action potential of whole-forearm flexors: A clinical biomarker for inclusion body myositis.

Inclusion body myositis, viral infections, and TDP-43: a narrative review.

Assessing PET/CT's diagnostic accuracy in idiopathic myopathies.

Diagnosing and characterizing inflammatory myopathies at an Australian tertiary public hospital: Resource utilization and direct healthcare costs.

Effect of sirolimus on muscle in inclusion body myositis observed with magnetic resonance imaging and spectroscopy.

Evaluation of Neuromuscular Diseases and Complaints by Quantitative Muscle MRI.

Myositis-associated antibodies predict the severity of lung involvement in adult patients with inflammatory myositis - a cohort study of 70 adult patients with myositis in a single center.

Revealing myopathy spectrum: integrating transcriptional and clinical features of human skeletal muscles with varying health conditions.

Quantum simulation of Pauli channels and dynamical maps: Algorithm and implementation.

Identification of distinct immune signatures in inclusion body myositis by peripheral blood immunophenotyping using machine learning models.

Effects of sporadic inclusion body myositis on skeletal muscle fibre type specific morphology and markers of regeneration and inflammation.

Interpreting a Delayed Workup of Idiopathic Inflammatory Myopathy.

Sarcopenia assessed by DXA and hand-grip dynamometer: a potential marker of damage, disability and myokines imbalance in inflammatory myopathies.

Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey.

272nd ENMC international workshop: 10 Years of progress - revision of the ENMC 2013 diagnostic criteria for inclusion body myositis and clinical trial readiness. 16-18 June 2023, Hoofddorp, The Netherlands.

Paraneoplastic myopathies.

Does inspiratory muscle training improve lung function and quality of life in people with inclusion body myositis? A pilot study.